Specific interactions of growth hormone (GH) with GH-receptors and GH-binding proteins in vivo in genetically GH-deficient Ames dwarf mice

被引:0
|
作者
Turyn, D
Dominici, FP
Sotelo, AI
Bartke, A [1 ]
机构
[1] So Illinois Univ, Dept Physiol, Sch Med, Carbondale, IL 62901 USA
[2] UBA, CONICET, Fac Farm & Bioquim, Inst Quim & Fisioquim Biol, Buenos Aires, DF, Argentina
来源
GROWTH REGULATION | 1997年 / 7卷 / 01期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The fate of exogenous radiolabeled growth hormone (I-125-hGH) was studied in Ames dwarf mice, which do not express growth hormone (GH) or, prolactin (PRL) genes; Labeled GH was injected in low amounts that did not exceed the normal physiological GH concentration in mice. Binding of most of the injected I-125-hGH by the GH-binding proteins (GHBPs) present in plasma represents the first step in the handling of this material in vivo. The decay curve followed a two-compartment model and gave the equation: Conc = 2.807e(-0 0067t) + 15301e(-0.0647t) (coefficient of determination 0.9986 +/- 0.0019), while in normal mice, GH decay followed a three-compartment model as we have previously reported. The fast compartment with t(1/2) of 1-2 min was virtually absent in dwarf mice, and chromatographic studies revealed the disappearance of free GH in these mice. We also present evidence of the labeled GH-forming complexes, presumably with GHBPs under in vivo conditions. The second step of processing labeled GH in vivo is the uptake by the liver, which was slower in dwarf than in normal mice (30-45 vs 15 min). Moreover, a lower GH uptake was found in dwarf than in normal mice (L/B ratio of 1.75 +/- 0.29 [30 min] vs L/B ratio of 3.68 +/- 0.33 [15 min], respectively) due to lower concentration of free GH in plasma and to the reduced number of GH-receptors (GHRs). The radioactive material present in the liver was compatible with I-125- hGH-GHR complexes with Stokes radius of 59 Angstrom. In summary, we provide evidence that plasma of dwarf mice contains proteins capable of binding GH in vivo and probably representing GHBPs not complexed with GH. The presence of these proteins modified the pharmacokinetics of I-125-hGH in plasma and its subsequent uptake by the liver. The presence of these binding proteins in the absence of endogenous GH suggests that a fraction of total GHBPs tone class?) is independent of GH concentration.
引用
收藏
页码:2 / 8
页数:7
相关论文
共 50 条
  • [21] Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy
    Wirén, L
    Boguszewski, CL
    Johannsson, G
    CLINICAL ENDOCRINOLOGY, 2002, 57 (02) : 235 - 239
  • [22] GROWTH HORMONE-RELEASING HORMONE PEPTIDE AND MESSENGER-RNA ARE OVEREXPRESSED IN GH-DEFICIENT AMES DWARF MICE
    PHELPS, CJ
    DALCIK, H
    ENDO, H
    TALAMANTES, F
    HURLEY, DL
    ENDOCRINOLOGY, 1993, 133 (06) : 3034 - 3037
  • [23] EFFECTIVENESS OF GROWTH-HORMONE (GH) THERAPY IN GH-DEFICIENT CHILDREN AND NON-GH-DEFICIENT SHORT CHILDREN
    BOZZOLA, M
    CISTERNINO, M
    BISCALDI, I
    MAGHNIE, M
    VALTORTA, A
    MORETTA, A
    SEVERI, F
    EUROPEAN JOURNAL OF PEDIATRICS, 1988, 147 (03) : 248 - 251
  • [24] The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults
    Cuneo, RC
    Judd, S
    Wallace, JD
    Perry-Keene, D
    Burger, H
    Lim-Tio, S
    Strauss, B
    Stockigt, J
    Topliss, D
    Alford, F
    Hew, L
    Bode, H
    Conway, A
    Handelsman, D
    Dunn, S
    Boyages, S
    Cheung, NW
    Hurley, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01): : 107 - 116
  • [25] The relationship of growth rate, plasma growth hormone (GH) concentration, and GH-binding protein
    Phillip, M
    Chalew, SA
    McCarter, RJ
    Amit, T
    Kowarski, AA
    Hochberg, Z
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (04): : 424 - 429
  • [26] Growth hormone (GH) and estradiol regulation of membrane-associated GH binding protein and GH receptors in GH releasing hormone transgenic mice
    González, L
    Sotelo, AI
    Bartke, A
    Turyn, D
    GROWTH HORMONE & IGF RESEARCH, 2001, 11 (01) : 34 - 40
  • [27] Growth hormone (GH) assays: Influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein
    Jansson, C
    Boguszewski, C
    Rosberg, S
    Carlsson, L
    AlbertssonWikland, K
    CLINICAL CHEMISTRY, 1997, 43 (06) : 950 - 956
  • [28] THE EFFECT OF HUMAN GROWTH-HORMONE THERAPY ON GH BINDING-PROTEIN IN GH-DEFICIENT CHILDREN
    HOCHBERG, Z
    BARKEY, RJ
    EVEN, L
    PELEG, I
    YOUDIM, MBH
    AMIT, T
    ACTA ENDOCRINOLOGICA, 1991, 125 (01): : 23 - 27
  • [29] In vivo growth hormone administration alters antioxidative enzymes in GH-deficient mice
    Brown-Borg, HM
    Rakoczy, SG
    Broden, M
    FASEB JOURNAL, 2003, 17 (04): : A447 - A447
  • [30] Predictors of Bone Responsiveness to Growth Hormone (GH) Replacement in Adult GH-Deficient Patients
    Alessandro Rossini
    Roberto Lanzi
    Marco Losa
    Marcella Sirtori
    Elisa Gatti
    Sara Madaschi
    Chiara Molinari
    Isabella Villa
    Marina Scavini
    Alessandro Rubinacci
    Calcified Tissue International, 2011, 88 : 304 - 313